PLS
During a busy week for Oxford PharmaGenesis, a successful Open Pharma roundtable and ISMPP EU conference were followed by a plenary presentation at the opening session of CBI’s 7th Annual Clinical Data Disclosure, Transparency & Plain Language Summaries Conference in Miami, FL, USA (22–24 January 2020).
Read MoreOxford PharmaGenesis is proud to announce that its annual charity donation is being made to Evidence Aid, an Oxford-based global charity that champions evidence-based humanitarian action in places threatened by disaster.
Read MoreOxford PharmaGenesis was delighted to attend the West Meeting of the International Society for Medical Publication Professionals (ISMPP), which took place on 14 and 15 November 2019 in San Diego, CA, USA.
Read MoreMaureen Lloyd,1 Cynthia K Barbitsch,2 Mary Voehl Hirsch,3 Antonia Panayi,4 Eric Southam5
Read MoreContinued growth has led Oxford PharmaGenesis, the leading HealthScience communications consultancy, to create a new UK office in Cambridge.
Read MoreIn mid-November Barcelona played host to the World Orphan Drug Congress 2019, Europe’s largest commercially focused conference for the rare disease community. Representatives from Oxford PharmaGenesis were in attendance over the 3-day meeting. The conference was broad-ranging in terms of sessions and speakers; however, there were some sessions of particular note.
Read MoreEmpowerment, not tokenism. Earlier this month, members of the Oxford PharmaGenesis Patient Engagement Team attended the annual educational event hosted by the Project Management Society in London. The event was held at the British Academy on the Mall, and featured several speakers and an expert panel selected to explore what it means to co-create with […]
Read MoreOxford PharmaGenesis Inc. has been named as a Great Place to Work® for the third consecutive year!
Read MoreAt the October meeting of the MedComms Brunch Club in Oxford, employees of Oxford PharmaGenesis used this year’s Open Access Week as an opportunity to launch the Open Pharma position statement on open access and to present Oxford PharmaGenesis-funded research on open access, clinical trial transparency and the role of professional medical writing support.
Read MoreOxford PharmaGenesis was delighted to attend the recent eyeforpharma Patient Summit Europe in London.
Read More